Recent Company News

• 12:25 PM ET Jun 04, 2026
  

  Transcript Intelligence: Pharming Group at Jefferies Global Healthcare Conference

• 08:20 AM ET Jun 04, 2026
  

  Healthcare, retail and travel the top performers; media, telecom and tech the big laggards:

• 04:13 AM ET Jun 04, 2026
  

  StreetAccount Summary - Hausse/Baisse en séance : Europe, milieu de matinée

• 04:02 AM ET Jun 02, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:57 AM ET Jun 04, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:01 AM ET Jun 04, 2026
  

  Pharming announces US FDA acceptance of sNDA resubmission for Joenja (leniolisib) to treat children aged 4 to 11 years with APDS (€1.06, 0.00)

• 03:31 PM ET May 22, 2026
  

  Pharming Group announces EC marketing authorization for Joenja (€1.12, 0.00)

• 07:40 AM ET May 20, 2026
  

  Jupiter Neurosciences secures $100M term sheet for exclusive U.S. rights to ALA-002 ($0.32, 0.00)